Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9536271rdf:typepubmed:Citationlld:pubmed
pubmed-article:9536271lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:9536271lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9536271lifeskim:mentionsumls-concept:C0521009lld:lifeskim
pubmed-article:9536271lifeskim:mentionsumls-concept:C0014442lld:lifeskim
pubmed-article:9536271lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:9536271lifeskim:mentionsumls-concept:C0033262lld:lifeskim
pubmed-article:9536271lifeskim:mentionsumls-concept:C0012860lld:lifeskim
pubmed-article:9536271lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9536271lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:9536271lifeskim:mentionsumls-concept:C0300918lld:lifeskim
pubmed-article:9536271pubmed:issue1lld:pubmed
pubmed-article:9536271pubmed:dateCreated1998-4-15lld:pubmed
pubmed-article:9536271pubmed:abstractTextClones of human colon carcinoma (WiDr), ovarian carcinoma (SK-OV-3), and Chinese hamster V79 cells expressing the nitroreductase enzyme (NR) from E. coli B were 52-, 225- and 177-fold respectively more sensitive to a 24-h incubation with the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) than the parent lines. The IC50s of non-NR-expressing bystander cells were measured in the presence of differing proportions of NR-expressing cells. The shift in IC50 was used to calculate a value for the bystander effect, termed the transmission efficiency (TE), which is the decrease in IC50 due to bystander effect as a percentage of the maximum decrease possible. The percentage of NR-expressing cells for which the TE was 50%, (the TE50) is a single datum of bystander efficacy. WiDr and V79 cell lines, had a similar TE50 of approximately 2%. SK-OV-3 gave a lower value of 0.3%. These TE50 correlate with concentrations of cytosolic NR activity, which is distinguished from endogenous DT diaphorase activity by kinetic differences. A novel method is described which enables both DNA crosslinks and drug-induced single-strand breaks to be simultaneously quantified in a sedimentation assay. Using this technique, bystander DNA damage was demonstrated in V79 cells, of approximately 50% of that in activator cells.lld:pubmed
pubmed-article:9536271pubmed:languageenglld:pubmed
pubmed-article:9536271pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9536271pubmed:citationSubsetIMlld:pubmed
pubmed-article:9536271pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9536271pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9536271pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9536271pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9536271pubmed:statusMEDLINElld:pubmed
pubmed-article:9536271pubmed:monthJanlld:pubmed
pubmed-article:9536271pubmed:issn0969-7128lld:pubmed
pubmed-article:9536271pubmed:authorpubmed-author:DennyW AWAlld:pubmed
pubmed-article:9536271pubmed:authorpubmed-author:FordMMlld:pubmed
pubmed-article:9536271pubmed:authorpubmed-author:FriedlosFFlld:pubmed
pubmed-article:9536271pubmed:authorpubmed-author:SpringerCClld:pubmed
pubmed-article:9536271pubmed:authorpubmed-author:CourtSSlld:pubmed
pubmed-article:9536271pubmed:issnTypePrintlld:pubmed
pubmed-article:9536271pubmed:volume5lld:pubmed
pubmed-article:9536271pubmed:ownerNLMlld:pubmed
pubmed-article:9536271pubmed:authorsCompleteYlld:pubmed
pubmed-article:9536271pubmed:pagination105-12lld:pubmed
pubmed-article:9536271pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:meshHeadingpubmed-meshheading:9536271-...lld:pubmed
pubmed-article:9536271pubmed:year1998lld:pubmed
pubmed-article:9536271pubmed:articleTitleGene-directed enzyme prodrug therapy: quantitative bystander cytotoxicity and DNA damage induced by CB1954 in cells expressing bacterial nitroreductase.lld:pubmed
pubmed-article:9536271pubmed:affiliationCancer Research Campaign Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, UK.lld:pubmed
pubmed-article:9536271pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9536271pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9536271lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9536271lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9536271lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9536271lld:pubmed